Based on the clinicopathological data from the TCGA dataset, we found that CCNB2 mRNA expression in ccRCC samples increased with increasing stage level (p < 0.001) (Fig. 3B). This evidence concerns the gene CCNB2 and nonpapillary renal cell carcinoma.